Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.

scientific article

Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1074-5521(99)80073-8
P698PubMed publication ID10322124

P50authorJonathan B. ChairesQ41509784
P2093author name stringQu X
Bailly C
Graves DE
Prudhomme M
P2860cites workStructural comparison of anticancer drug-DNA complexes: adriamycin and daunomycinQ27683811
Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolutionQ27728615
Solution structure of the esperamicin A1-DNA complexQ27734745
Solution structure of the calicheamicin gamma 1I-DNA complexQ27734746
Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complexQ27735003
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinasesQ34675057
Production and biological activity of rebeccamycin, a novel antitumor agent.Q34685566
DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycinQ34739014
Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.Q34743346
Criteria for the mode of binding of DNA binding agents.Q36684372
Biophysical chemistry of the daunomycin-DNA interaction.Q37951653
Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activityQ39750512
Strategies for the design of minor groove binders: a re-evaluation based on the emergence of site-selective carbohydrate bindersQ40999780
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experienceQ41686970
Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycleQ42542800
Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial propertiesQ42552785
16 Analysis of equilibrium and kinetic measurements to determine thermodynamic origins of stability and specificity and mechanism of formation of site-specific complexes between proteins and helical DNAQ44249816
Polyelectrolyte effects on site-binding equilibria with application to the intercalation of drugs into DNA.Q52684636
Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivativesQ67507590
Parsing the free energy of anthracycline antibiotic binding to DNAQ71127748
A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterizationQ72240543
Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycinQ74095197
AT2433-A1, AT2433-A2, AT2433-B1, and AT2433-B2 novel antitumor antibiotic compounds produced by Actinomadura melliaura. Taxonomy, fermentation, isolation and biological properties.Q78420505
Isolation and structure of rebeccamycin - a new antitumor antibiotic from nocardia aerocoligenesQ104154933
P433issue5
P304page(s)277-286
P577publication date1999-05-01
P1433published inChemistry and BiologyQ15758410
P1476titleCalories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition
P478volume6